Literature DB >> 18536745

On the fitting of binding data when receptor dimerization is suspected.

J Giraldo1.   

Abstract

Mechanistic and empirical modelling are compared in context of dimeric receptors. In particular, the supposed advantages of the two-state dimer model for fitting of binding data with respect to classical approaches such as the two-independent sites model are investigated. The two models are revisited from both the mechanistic and empirical point of views. The problem of overparameterized models and the benefits of the concurrent use of mechanistic and empirical models for mechanism analysis are discussed. The pros and cons of mathematical models are examined with special emphasis given to the interpretation of the connection between the shapes of the curves and receptor cooperativity. It is shown that a given pharmacological phenotype (curve shape) can be obtained from different receptor genotypes (as, for instance, non-interconvertible monomeric receptor species, receptor-G protein interactions and dimeric receptors), though values of the Hill coefficient greater than one are indicative of receptor oligomerization. The existence of a relationship between the recently defined dimer cooperativity index and the more familiar Hill coefficient is proven.

Mesh:

Substances:

Year:  2008        PMID: 18536745      PMCID: PMC2527846          DOI: 10.1038/bjp.2008.234

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Empirical models and Hill coefficients.

Authors:  Jesús Giraldo
Journal:  Trends Pharmacol Sci       Date:  2003-02       Impact factor: 14.819

2.  Closed state of both binding domains of homodimeric mGlu receptors is required for full activity.

Authors:  Julie Kniazeff; Anne-Sophie Bessis; Damien Maurel; Hervé Ansanay; Laurent Prézeau; Jean-Philippe Pin
Journal:  Nat Struct Mol Biol       Date:  2004-07-04       Impact factor: 15.369

Review 3.  Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions.

Authors:  László Szidonya; Miklós Cserzo; László Hunyady
Journal:  J Endocrinol       Date:  2008-03       Impact factor: 4.286

4.  How and why do GPCRs dimerize?

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2008-04-01       Impact factor: 14.819

5.  On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine.

Authors:  A Karlin
Journal:  J Theor Biol       Date:  1967-08       Impact factor: 2.691

6.  Assessment of a ternary model for the binding of agonists to neurohumoral receptors.

Authors:  T W Lee; M J Sole; J W Wells
Journal:  Biochemistry       Date:  1986-11-04       Impact factor: 3.162

7.  Ligand binding to the membrane-bound acetylcholine receptor from Torpedo marmorata: a complete mathematical analysis.

Authors:  H Prinz; A Maelicke
Journal:  Biochemistry       Date:  1992-07-28       Impact factor: 3.162

8.  Identification of a serotonin/glutamate receptor complex implicated in psychosis.

Authors:  Javier González-Maeso; Rosalind L Ang; Tony Yuen; Pokman Chan; Noelia V Weisstaub; Juan F López-Giménez; Mingming Zhou; Yuuya Okawa; Luis F Callado; Graeme Milligan; Jay A Gingrich; Marta Filizola; J Javier Meana; Stuart C Sealfon
Journal:  Nature       Date:  2008-02-24       Impact factor: 49.962

9.  Negative cooperativity of glutamate binding in the dimeric metabotropic glutamate receptor subtype 1.

Authors:  Yoshikazu Suzuki; Eiko Moriyoshi; Daisuke Tsuchiya; Hisato Jingami
Journal:  J Biol Chem       Date:  2004-06-15       Impact factor: 5.157

10.  Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting.

Authors:  R Mattera; B J Pitts; M L Entman; L Birnbaumer
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

View more
  14 in total

1.  Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

Authors:  José L Moreno; Terrell Holloway; Laura Albizu; Stuart C Sealfon; Javier González-Maeso
Journal:  Neurosci Lett       Date:  2011-01-27       Impact factor: 3.046

Review 2.  Biased signalling and allosteric machines: new vistas and challenges for drug discovery.

Authors:  Terry P Kenakin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 4.  G-protein-coupled receptor heteromers or how neurons can display differently flavoured patterns in response to the same neurotransmitter.

Authors:  Rafael Franco
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

Review 5.  Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system.

Authors:  X Rovira; M Vivó; J Serra; D Roche; P G Strange; J Giraldo
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

6.  GPCR theme editorial.

Authors:  G Milligan; J C McGrath
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

7.  Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors.

Authors:  Laura Albizu; Terrell Holloway; Javier González-Maeso; Stuart C Sealfon
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

Review 8.  Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.

Authors:  A de Bartolomeis; E F Buonaguro; F Iasevoli
Journal:  Psychopharmacology (Berl)       Date:  2012-11-21       Impact factor: 4.530

9.  Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target.

Authors:  Megan Morse; Elizabeth Tran; Haiyan Sun; Robert Levenson; Ye Fang
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

10.  Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family.

Authors:  Megan Morse; Haiyan Sun; Elizabeth Tran; Robert Levenson; Ye Fang
Journal:  BMC Pharmacol Toxicol       Date:  2013-03-12       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.